Mitral valve regurgitation happens when the valve between the heart's upper and lower left chambers doesn't close properly, letting blood leak backward. Mild cases need no treatment, but significant regurgitation strains the heart over time. Treatment ranges from medications to manage symptoms to surgery or catheter-based procedures to repair or replace the valve.
What's actually going on in research
Trials are testing transcatheter techniques that fix the valve through a vein rather than open-heart surgery, newer devices for valve repair and replacement, and medical therapies to protect the heart while patients wait for intervention. Researchers are also studying which patients benefit most from early intervention before symptoms develop.
Transcatheter edge-to-edge repair
This catheter procedure clips the leaking valve flaps together without open-heart surgery. Trials are expanding it to more patient types and testing next-generation devices that may work for a wider range of valve anatomy.
Transcatheter valve replacement
Devices that replace the entire mitral valve through a catheter are being tested in patients who can't tolerate surgery. Early results show promise but trials are still refining which patients are the right candidates.
Early intervention trials
Studies are testing whether fixing significant leakage before symptoms appear preserves heart function better than waiting. This could change the standard of care for people with severe regurgitation who currently feel well.
What to know before you search
Eligibility typically depends on how severe the leakage is, heart function, the cause of regurgitation, prior valve procedures, and whether you have symptoms. Some trials specifically enroll patients who don't yet have symptoms.
What types of trials are currently open
- Device trials — Testing catheter-based clips, rings, and replacement valves that repair or replace the mitral valve without open-heart surgery, often comparing new devices to existing ones.
- Surgical technique trials — Comparing different approaches to open-heart repair, or testing whether surgery can be delayed safely in patients with no symptoms.
- Medical management trials — Testing medications — including drugs used for heart failure — to reduce strain on the heart and slow progression in patients who are not yet candidates for a procedure.
- Imaging and monitoring trials — Testing whether specific imaging tests or biomarkers can identify patients who need early treatment before the heart weakens.
Recently added Mitral Valve Regurgitation trials
Early Feasibility Study of the Capstan Medical TMVR System
This early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.
Complete advanced heart imaging scans to map cardiac energy patterns
The study is designed to establish a comprehensive myocardial energetic phenotype across a broad spectrum of cardiovascular diseases using phosphorus-31 magnetic resonance spectroscopy (31P-MRS). And the study plans to enroll 1,000 participants, comprising healthy volunteers and patients with diverse cardiac conditions. Target cohorts primarily encompass heart failure syndromes and various cardiomyopathies, with a particular focus on non-ischemic and hypertrophic phenotypes, as well as ischemic and other structural etiologies. By integrating 31-MRS with multiparametric standard CMR, this study aims to map disease-specific metabolic signatures. The primary outcome measure is the myocardial PCr/ATP ratio, serving as a direct in vivo marker of energetic impairment. Furthermore, the study aims to explore the coupling between metabolic phenotypes and structural remodeling (tissue characterization), mechanical dysfunction, and systemic clinical biomarkers. Crucially, the study will evaluate the prognostic value of these energetic phenotypes in predicting clinical outcomes, ultimately providing novel insights into the pathophysiology and risk stratification of cardiomyopathies and heart failure.
Find Mitral Valve Regurgitation trials matched specifically to you
Answer 3 quick questions and we'll show you trials that fit your situation.